COMMUNIQUÉS West-GlobeNewswire

PhaseBio Reports Third Quarter 2018 Financial and Business Results
29/11/2018
Closed initial public offering that raised $43.0 million in net proceeds Demonstrated proof of concept for PB2452, supporting continued development for the reversal of antiplatelet activity of ticagrelor MALVERN, Pa. [...]
MPX Reports Financial Results for Its Fiscal Second Quarter of 2019
29/11/2018
Quarterly Revenues increased 233% to $14.7 Million TORONTO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) today reports financial results for its [...]
Scholar Rock to Present at the BMO 2018 Prescriptions for Success Healthcare Conference
29/11/2018
CAMBRIDGE, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth [...]
Sol-Gel Technologies Announces Participation in Upcoming Investor Conference
29/11/2018
NESS ZIONA, Israel, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
ChemoCentryx’s Novel Small Molecule Antagonists of Checkpoint Inhibitors and Chemokine Receptors to be Presented at the American Association for Cancer Research (AACR) Tumor Immunology and Immunotherapy Conference
29/11/2018
-- Studies highlight CCX4503, a unique small molecule inhibitor of immune checkpoint molecules PD-1/PD-L1, demonstrates anti-tumor efficacy in vivo -- -- Company’s studies also show CCR4 inhibition enhances [...]
Principia Biopharma Reports Positive PRN1008 Phase 2 Top-Line Results and Initiates Phase 3 Pemphigus Program
29/11/2018
- Achieved Phase 2 primary endpoint – over 50% of patients attained Control of Disease Activity within four weeks of starting PRN1008 - - Demonstrated sustained clinical efficacy at 12 weeks of therapy, a secondary [...]
SI-BONE, Inc. Reports Third Quarter 2018 Financial Results
29/11/2018
SANTA CLARA, Calif., Nov. 29, 2018 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System [...]
Atara Biotherapeutics Highlights Next-Generation and Off-the-Shelf, Allogeneic CAR T Technologies and Pipeline
29/11/2018
Atara has assembled core technologies and capabilities to develop next-generation and off-the-shelf, allogeneic CAR T immunotherapies, collaborating with academic leaders as well as leveraging the Company’s world-class [...]
Molecular You Receives Innovation Award for Advancing Personalized Health Through its Biomarker Health Assessments
29/11/2018
VANCOUVER, British Columbia, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Molecular You is proud to announce it is a 2018 recipient of a TEC Edmonton Spin-Off Achievement Award for the commercialization of personalized health [...]
CORRECTING and REPLACING -- US FDA approves Invivoscribe LeukoStrat CDx FLT3 Mutation Assay as CDx and Astellas drug XOSPATA (gilteritinib fumarate) for treatment of AML patients in the US
29/11/2018
Invivoscribe also Receives National Reimbursement for CDx Assay in Japan SAN DIEGO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Invivoscribe, Inc., please note the [...]
EssilorLuxottica - Press Release: EssilorLuxottica 2018 Combined Shareholders' Meeting
29/11/2018
EssilorLuxottica 2018 Combined Shareholders' Meeting Charenton-Le-Pont (November 29, 2018 - 8:00 pm) - EssilorLuxottica held its first Combined General Meeting today at the Espace Grande Arche at La Défense, chaired by [...]
EssilorLuxottica - Communiqué : Assemblée Générale Mixte EssilorLuxottica 2018
29/11/2018
Assemblée Générale Mixte EssilorLuxottica 2018 Charenton-le-Pont (29 novembre 2018 - 20:00) - EssilorLuxottica a tenu aujourd'hui sa première Assemblée Générale Mixte à l'Espace Grande Arche à La Défense, présidée par [...]
Constellation Pharmaceuticals to Present at BMO Healthcare Conference
29/11/2018
CAMBRIDGE, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]
Resolutions passed at the annual general meeting of Chr. Hansen Holding A/S
29/11/2018
Company Announcement No. 24/2018 November 29, 2018 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 [...]
Tauriga Sciences Inc. to Proceed in Development and Launch of Cannabis Infused Chewing Gum Product Line
29/11/2018
New York, NY, Nov. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. ( TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]
Canopy Growth Completes Strategic Extract Supply Agreement with MediPharm Labs
29/11/2018
SMITHS FALLS & BARRIE, Ontario, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) and MediPharm Labs Inc. (“MediPharm”), a specialized cannabis [...]
PotNetwork Holdings, Inc.’s Diamond CBD Launches Program To Sell Its Products in Shopping Malls Across America on Black Friday at Broward Mall in South Florida
29/11/2018
New Program Focusing on Educating Consumers on the Benefits of Diamond CBD to Build Brand Preference FORT LAUDERDALE, Fla., Nov. 29, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink: POTN [...]
Canadian Tech Company B-Temia Enters Into a $6.9M USD US Army / Lockheed Martin Agreement
29/11/2018
B-Temia and Lockheed Martin Team Up to Optimize ONYX™ Exoskeleton QUÉBEC CITY, Nov. 29, 2018 (GLOBE NEWSWIRE) -- B-Temia, a Canadian robotics tech company and leader in the human mobility market, announced its [...]
B-Temia, une société canadienne de technologie conclut une entente de 6,9 millions $ US avec l’armée américaine / Lockheed Martin
29/11/2018
B-Temia et Lockheed Martin font équipe en vue d’optimiser l’exosquelette ONYX™ QUÉBEC, 29 nov. 2018 (GLOBE NEWSWIRE) -- B-Temia, une société de technologie robotique canadienne à la tête du marché de la mobilité humaine [...]

Pages